Evidence map›Paper›PMID 30792136›Full record

ArticleSchizophrenia research2019

Impact of "psychosis risk" identification: Examining predictors of how youth view themselves.

Lawrence H Yang, Kristen A Woodberry, Bruce G Link, Cheryl M Corcoran, Caitlin Bryant, Daniel I Shapiro, Donna Downing, Ragy R Girgis, Gary Brucato, Debbie Huang and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Schizophrenia research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Lawrence H YangNew York University College of Global Public Health, 715 Broadway, New York, NY 10003, USA; Mailman School of Public Health, Columbia University, 722 W 168th St, New York, NY 10032, USA. Electronic address: Lawrence.yang@nyu.edu.
Kristen A WoodberryMaine Medical Center Research Institute, Portland, ME 04102, USA; Commonwealth Research Center (CRC), Beth Israel Deaconess Medical Center (BIDMC), Boston, MA 02115, USA; Beth Israel Deaconess Medical Center (BIDMC), Boston, MA 02115, USA; Harvard Medical School, Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA.
Bruce G LinkUniversity of California at Riverside, 900 University Ave, Riverside, CA 92521, USA.
Cheryl M CorcoranIcahn School of Medicine at Mount Sinai, Department of Psychiatry, 1 Gustave L. Levy Pl., New York, NY 10029, USA; Mental Illness Research, Education, and Clinical Center (MIRECC VISN 2), James J. Peter Veterans Affairs Medical Center, 130 West Kingsbridge Rd, Bronx, NY 10468, USA.
Caitlin BryantCommonwealth Research Center (CRC), Beth Israel Deaconess Medical Center (BIDMC), Boston, MA 02115, USA; University of Massachusetts Boston, 100 Morrissey Boulevard, Boston, MA 02125, USA.
Daniel I ShapiroCommonwealth Research Center (CRC), Beth Israel Deaconess Medical Center (BIDMC), Boston, MA 02115, USA; Beth Israel Deaconess Medical Center (BIDMC), Boston, MA 02115, USA; Harvard Medical School, Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA.
Donna DowningMaine Medical Center Research Institute, Portland, ME 04102, USA.
Ragy R GirgisNew York State Psychiatric Institute, Columbia University Department of Psychiatry, 1051 Riverside Dr. New York, NY 10032, USA; The Center of Prevention and Evaluation (COPE), New York State Psychiatric Institute, Columbia University Medical Center, 1051 Riverside Dr., New York, NY 10032, USA.
Gary BrucatoNew York State Psychiatric Institute, Columbia University Department of Psychiatry, 1051 Riverside Dr. New York, NY 10032, USA; The Center of Prevention and Evaluation (COPE), New York State Psychiatric Institute, Columbia University Medical Center, 1051 Riverside Dr., New York, NY 10032, USA.
Debbie HuangMailman School of Public Health, Columbia University, 722 W 168th St, New York, NY 10032, USA.
Francesca M CrumpThe Center of Prevention and Evaluation (COPE), New York State Psychiatric Institute, Columbia University Medical Center, 1051 Riverside Dr., New York, NY 10032, USA.
Mary VerdiMaine Medical Center Research Institute, Portland, ME 04102, USA.
William R McFarlaneMaine Medical Center Research Institute, Portland, ME 04102, USA; Department of Psychiatry, School of Medicine, Tufts University, 0 Park Plaza #1101, Boston, MA 02116, USA.
Larry J SeidmanCommonwealth Research Center (CRC), Beth Israel Deaconess Medical Center (BIDMC), Boston, MA 02115, USA; Beth Israel Deaconess Medical Center (BIDMC), Boston, MA 02115, USA; Harvard Medical School, Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA.

Funding

Administrative Supplement Harmonization of At Risk Multisite Observational Networks for Youth(HARMONY)U01MH081928 · NIMH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI STONE, WILLIAM SETH · 2008 to 2018
$7.1M
Thought disorder and social cognition in clinical risk states for schizophreniaR01MH107558 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI CORCORAN, CHERYL MARY · 2016 to 2020
$3.3M
Stigma Associated with a High-Risk State for PsychosisR01MH096027 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SUSSER, EZRA S., YANG, LAWRENCE H · 2012 to 2016
$2.6M
Innovative Intervention for Reducing Stress Reactivity and Risk for PsychosisK23MH102358 · NIMH · MAINEHEALTH · PI WOODBERRY, KRISTEN ANNE · 2014 to 2017
$722k
Validating Biomarkers for the Prodrome and Transition to Psychosis in ShanghaiR01MH101052 · NIMH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI LI, HUIJUN, MCCARLEY, ROBERT W · 2013 to 2015
$600k
Broadening the Investigation of Psychosis Prodrome to Different Cultural GroupsR21MH093294 · NIMH · FLORIDA AGRICULTURAL AND MECHANICAL UNIV · PI LI, HUIJUN, SEIDMAN, LARRY J · 2012 to 2013
$249k
NIMH NIH HHS K23 MH102358NIMH NIH HHS R01 MH096027NIMH NIH HHS R01 MH101052NIMH NIH HHS R01 MH107558NIMH NIH HHS R21 MH093294NIMH NIH HHS U01 MH081928
6 · The paper itself

Abstract

backgroundIdentifying young people as at clinical high-risk (CHR) for psychosis affords opportunities for intervention to possibly prevent psychosis onset. Yet such CHR identification could plausibly increase stigma. We do not know whether these youth already perceive themselves to be at psychosis-risk (PR) or how their being told they are at PR might impact how they think about themselves.

methods148 CHR youth were asked about labels they had been given by others (labeling by others) or with which they personally identified (self-labeling). They were then asked which had the greatest impact on how they thought about themselves. We evaluated whether being told vs. thinking they were at PR had stronger effects.

findingsThe majority identified nonpsychotic disorders rather than PR labels as having the greatest impact on sense of self (67.6% vs. 27.7%). However, participants who identified themselves as at PR had an 8.8 (95% CI = 2.0-39.1) increase in the odds of the PR label having the greatest impact (p < 0.01). Additionally, having been told by others that they were at PR was associated with a 4.0 increase in odds (95% CI = 1.1-15.0) that the PR label had the most impact (p < 0.05).

interpretationNonpsychotic disorder labels appear to have a greater impact on CHR youth than psychosis-risk labels. However, thinking they are at PR, and, secondarily, being told they are at PR, appears to increase the relative impact of the PR label. Understanding self- and other-labeling may be important to how young people think of themselves, and may inform early intervention strategies.

Indexed as

Identification, PsychologicalSelf ConceptAdaptation, PsychologicalAdolescentAdultChildFeedback, PsychologicalFemaleHumansMalePsychotic DisordersRiskSocial StigmaYoung AdultClinical high risk state for psychosisEarly interventionIdentityPsychosis riskStigma

Identifiers

PMID30792136
PMCPMC7079577

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.